Pharmaceutical Ads Drive Consumers Online, Study Says

Share this article:
A new study estimated that 26.3 million U.S. adults actively seek pharmaceutical information on the Internet, up from 11.6 million a year and a half ago.


While these consumers recall television and print advertising of pharmaceuticals, more than three-quarters remembered seeing ads for medical drugs online, according to Manhattan Research LLC. This reflects the multichannel nature of the online pharmaceutical end user, the New York healthcare marketing and services company said.


The trends were pulled from Manhattan Research's ePharma Consumer v2.0 data set analyzing consumers who seek medical information online. The data was collected in December and January by polling online 3,000 U.S. adults.


The report said nearly half of these consumers reported visiting the Internet after seeing an ad for prescription drugs in offline media like TV or magazines. They visited the Internet immediately after viewing the offline ad.


Sites most popular with these consumers are for products like Allegra, Clarinex, Celebrex, Nexium's purplepill.com, Zoloft, Zocor, Glucophage, Advair, Imitrex, Ambien, Flonase, Paxil, Lipitor, Prevacid, Viagra and Zyrtec.


Share this article:
You must be a registered member of Direct Marketing News to post a comment.
close

Next Article in Data/Analytics

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

Featured Listings

More in Data/Analytics

Acxiom East?

Acxiom East?

Ogilvy & Mather launches OgilvyAmp, a think tank for data-driven marketers headed by expatriates from Little Rock's best-known data company.

Epicor to Acquire Analytics Provider QuantiSense

Epicor to Acquire Analytics Provider QuantiSense

Retail solutions provider seeks to up its data analytics game for large and midsized retailers.

One Third of Companies Fail to Measure Data Quality ROI

One Third of Companies Fail to Measure Data ...

Twenty percent of companies assume their data quality tools pay off, while another 10% doesn't monitor ROI at all.